Sale!

Anti-NMO Neuromyelitis Optica Antibody Aquaporin 4 Test

Original price was: $226.Current price is: $162.

-28%

The Anti-NMO Neuromyelitis Optica Antibody Aquaporin 4 Test is a specialized diagnostic tool that detects antibodies targeting aquaporin-4 water channels in the central nervous system. This crucial test helps diagnose neuromyelitis optica spectrum disorders (NMOSD), a severe autoimmune condition affecting the optic nerves and spinal cord. By identifying specific IgG antibodies, healthcare providers can differentiate NMOSD from multiple sclerosis and other neurological conditions, enabling targeted treatment approaches. The test provides essential information for developing personalized treatment plans and monitoring disease progression. Available for only $162 USD, this advanced immunological assessment offers rapid same-day results when samples are submitted by Tuesday or Friday mornings. Early detection through this specialized antibody testing can significantly improve patient outcomes and quality of life.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Anti-NMO Neuromyelitis Optica Antibody Aquaporin 4 Test

Understanding Neuromyelitis Optica Spectrum Disorders

Neuromyelitis optica spectrum disorders (NMOSD) represent a group of severe autoimmune conditions that primarily affect the central nervous system, specifically targeting the optic nerves and spinal cord. The Anti-NMO Neuromyelitis Optica Antibody Aquaporin 4 Test serves as a critical diagnostic tool in identifying these debilitating conditions, providing healthcare professionals with essential information for accurate diagnosis and targeted treatment strategies.

What This Revolutionary Test Measures

This advanced immunological assessment specifically detects IgG antibodies directed against aquaporin-4 (AQP4), which are water channel proteins abundantly expressed in astrocytes throughout the central nervous system. The presence of these autoantibodies indicates an autoimmune attack on the nervous system, distinguishing NMOSD from other neurological conditions like multiple sclerosis.

  • Detects anti-aquaporin-4 IgG antibodies with high specificity
  • Identifies autoimmune activity against central nervous system structures
  • Provides crucial differential diagnostic information
  • Helps monitor disease activity and treatment response

Who Should Consider This Essential Neurological Test?

This specialized testing is particularly important for individuals experiencing specific neurological symptoms that may indicate autoimmune nervous system disorders. Early detection can significantly impact treatment outcomes and quality of life.

Key Symptoms and Clinical Indicators

  • Severe optic neuritis with vision loss or eye pain
  • Transverse myelitis causing limb weakness or paralysis
  • Sensory disturbances including numbness or tingling
  • Bladder and bowel dysfunction
  • Persistent nausea, vomiting, or hiccups
  • Brainstem symptoms affecting breathing or swallowing
  • Unilateral or bilateral vision impairment
  • Progressive neurological deficits

Comprehensive Benefits of Neurological Autoimmune Testing

Undergoing the Anti-NMO Antibody Aquaporin 4 Test provides numerous advantages for both patients and healthcare providers, enabling more precise diagnosis and personalized treatment approaches.

Clinical Advantages

  • Accurate Diagnosis: Differentiates NMOSD from multiple sclerosis and other neurological conditions
  • Early Intervention: Enables prompt initiation of targeted immunotherapy
  • Treatment Guidance: Informs selection of appropriate therapeutic strategies
  • Prognostic Information: Helps predict disease course and potential complications
  • Monitoring Tool: Assists in tracking disease activity and treatment efficacy

Understanding Your Test Results

Interpreting your Anti-NMO Antibody Aquaporin 4 Test results requires professional medical expertise, but understanding the general implications can help you participate more actively in your healthcare decisions.

Result Interpretation Guidelines

  • Positive Result: Indicates the presence of anti-AQP4 antibodies, strongly supporting a diagnosis of NMOSD and requiring immediate neurological consultation
  • Negative Result: Does not completely rule out NMOSD, as some patients may have seronegative disease or require additional testing
  • Borderline Results: May require repeat testing or additional immunological assessments
  • Clinical Correlation: Results must be interpreted in the context of clinical symptoms and imaging findings

Test Pricing and Availability

We are committed to making advanced neurological testing accessible and affordable for patients across the United States.

Test Component Price (USD)
Discount Price $162
Regular Price $226

Testing Logistics

  • Turnaround Time: Same-day results when samples submitted Tuesday or Friday by 9 AM
  • Sample Requirements: 2 mL serum from SST tube OR 1 mL CSF in sterile container
  • Shipping Instructions: Refrigerated or frozen transport
  • Testing Methodology: Immunofluorescence Assay

Nationwide Accessibility

With branches strategically located throughout the United States, we ensure convenient access to this essential neurological testing. Our facilities in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, and numerous other cities provide comprehensive diagnostic services with the highest standards of quality and accuracy.

Take Control of Your Neurological Health Today

Don’t let uncertainty about neurological symptoms delay your path to proper diagnosis and effective treatment. The Anti-NMO Neuromyelitis Optica Antibody Aquaporin 4 Test provides the critical information needed to guide your neurological care with precision and confidence.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or speak with our neurological testing specialists. Early detection through advanced autoimmune antibody testing can make a significant difference in managing neurological conditions and preserving neurological function.